China (Mainland)
promotion qualify of tan block Lamivudine Intermediate – CTS purchase 173522-96-8 CAS NO.173522-96-8
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,MoneyGram,Other
- Product Details
Keywords
- promotion qualify of Lamivudine Intermediate – CTS
- tan block Lamivudine Intermediate – CTS
- purchase 173522-96-8
Quick Details
- ProName: promotion qualify of tan block Lamivu...
- CasNo: 173522-96-8
- Molecular Formula: C8H11N3O3·C7H6O3
- Appearance: White to off-white powder
- Application: 173522-96-8
- DeliveryTime: up to request
- PackAge: up to request
- Port: Any port in China
- ProductionCapacity: 100 Metric Ton/Year
- Purity: 99%+
- Storage: Store in cool and dry place.
- Transportation: up to request
- LimitNum: 1 Kilogram
Superiority
promotion qualify of tan block Lamivudine Intermediate – CTS purchase 173522-96-8
1.promotion qualify of Lamivudine Intermediate – CTS
2.tan block Lamivudine Intermediate – CTS
3.purchase 173522-96-8
4.C8H11N3O3·C7H6O3
Result of analysis
|
Item |
Standard |
Results |
|
Appearance |
White crystalline powder |
Complies |
|
Specific Optical Rotation |
-80.0°-85.0° |
-84.1° |
|
Melting Range |
140-165°C |
159.7-160.2°C |
|
Impurity
|
RRT=0.4,NMT 0.7% |
0.6% |
|
RRT=0.9,NMT 1.0% |
0.8% |
|
|
Purity |
98.0%Min |
98.29% |
|
Water by K.F. |
5.0% max |
4.97% |
|
Conclusion |
Complies with standard
|
|
|
Item |
Standard |
Results |
|
Appearance |
White crystalline powder |
Complies |
|
Specific Optical Rotation |
-80.0°-85.0° |
-84.1° |
|
Melting Range |
140-165°C |
159.7-160.2°C |
|
Impurity
|
RRT=0.4,NMT 0.7% |
0.6% |
|
RRT=0.9,NMT 1.0% |
0.8% |
|
|
Purity |
98.0%Min |
98.29% |
|
Water by K.F. |
5.0% max |
4.97% |
|
Conclusion |
Complies with standard
|
|
Lonzeal Pharmaceuticals is drug manufacturer with China/WHO/FDA/ANVISA GMP certificates. We supply pharmaceutical products to esteemed customers globally with high quality, competitive price and good service.
Details
About us
LONZEAL Pharmaceuticals is a leading manufacturing company covering finished formulation, active pharmaceutical ingredients and advanced intermediates. Our products and manufacturing site have been approved and inspected by stringent drug authorities such as USFDA, WHO, China NMPA, Brazil ANVISIA and India DCGI, based on which, we have been supplying to esteemed customers globally in the past 15 years with regulatory compliance and good quality.
Our current main products cover anti-virus, anti-depression and anti-neuropathic pain areas. Lonzeal has become one of the key manufacturers in the global supply of anti-HIV drugs and is providing support to the treatment need of over 4 Million patients each year worldwide.
